← All organizations
Highest phase reached
Phase 2
First clinical trial
May 2, 2019Last known activity
Jul 10, 2024
Timeline
2010s
- Jun 1, 2015
Context Therapeutics— Founded
Drugs by trial phase (6 distinct, 6 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT06515613Lead sponsorPhase 1Jul 10, 2024
- NCT06515613OfficialPhase 1Jul 10, 2024
- NCT06938711Lead sponsorPhase 1/Phase 2Jun 30, 2023
- NCT05618613Lead sponsorPhase 1/Phase 2Nov 22, 2022
- NCT04738292CollaboratorPhase 2Oct 5, 2021
- NCT04872608CollaboratorPhase 1Sep 9, 2021
- NCT03909152CollaboratorPhase 2May 2, 2019
Details
- Founded
- Philadelphia, PA, US Jun 1, 2015
- Last known activity
- Jul 10, 2024